Physician profile

Justin Harrington

Modesto, CA

NPI 1811525306

$22,927.80

in general payments reported to CMS, 2019-2025

5 companies · $20K in 2025

The $20K reported for 2025 was more than what 99% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$20,000.00
Education$353.87
Food and Beverage$153.93

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $20,000.00 2025
Sequoia Surgical, INC. $2,420.00 2021
Smith+Nephew, INC. $353.87 2024 N/A
Amgen INC. $125.00 2024 Evenity
Cornerstone Medical Associates, INC. $28.93 2024-2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Justin Harrington

$22,927.80

in general payments reported 2019-2025

Years
2021-2025
Top company
Arthrex, INC.
Context
The $20K reported for 2025 was more than what 99% of providers received nationally.

https://glasscript.com/doctor/11306419/justin-harrington

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.